Mandi L. Pratt-Chapman, PhD, is the associate center director for scientific communication and a professor of medicine at the George Washington University School of Medicine and Health Science in Washington, D.C. Her research addresses topics including health equity and cancer survivorship, with a focus on improving the health of lesbian, gay, bisexual, transgender, queer, and intersex populations.


We don’t currently have cancer screening guidelines tailored to LGBTQ patients, and I was working to address this problem. For example, transgender women usually retain their prostate and have PSA levels well under the cutoff for cisgender men. We need prostate screening guidelines that account for the fact that PSA levels that are cause for concern should be lower for transgender women. Many clinicians are figuring out what to do with LGBTQ oncology patients on a case-by-case basis, and the goal of this study was to lay the groundwork for better education and guidelines through systematic Sexual Orientation and Gender Identity (SOGI) data collection. We don’t yet have randomized clinical trials of this patient population, and the current guidelines are based on assumptions of cisgender/heterosexual status. We were just starting to make progress to answer these questions, and all my projects are now at risk.
I started my work on LGBTQ patient care 10 years ago after I came out. At the time, I focused on patient navigation and cancer survivorship workforce capacity. Now it feels like I'm being asked to literally change everything that I have spent more than a decade working on. All the progress I thought I had contributed to feels lost. I hope I can continue doing the work I feel passionate about, but I just don’t know if that will be possible.

